Perrigo's High Dividend Yield Raises Concerns Amid Weak Performance
Perrigo (PRGO), an over-the-counter drug manufacturer, currently offers a dividend yield of nearly 8.5%, but recent financial performance has been weak. The company reported declining core and organic sales in Q2 2026, along with significant drops in gross and operating margins. Despite maintaining its $0.29 per share dividend, concerns persist about the sustainability of this payout given ongoing operational challenges. The CEO abruptly left earlier this year, leaving an interim leader to manage operations while a replacement is sought. This leadership transition adds uncertainty as Perrigo continues with its 'Three-S' plan aimed at improving performance and reducing debt through asset sales. The company's long-term revenue decline raises questions about whether the high yield can be maintained. Investors are advised to consider these risks before investing in what appears to be a struggling consumer staples business facing both internal management issues and external market pressures.
Topics: consumer staples dividend risk earnings leadership change